mNo edit summary
mNo edit summary
 
(6 intermediate revisions by 6 users not shown)
Line 1: Line 1:
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trial Meta is a non-commercial open data platform and infrastructure that supports research on pragmatic trials. It collects and shares cleaned trial data and ratings using PRECIS-2, permitting multiple and varied meta-epidemiological studies to evaluate the effect of treatment on trials that have different levels of pragmatism and other design features.<br><br>Background<br><br>Pragmatic studies provide real-world evidence that can be used to make clinical decisions. However, the use of the term "pragmatic" is not consistent and its definition and evaluation requires further clarification. Pragmatic trials are intended to guide clinical practices and policy choices, rather than verify a physiological hypothesis or clinical hypothesis. A pragmatic trial should aim to be as close as possible to the real-world clinical practice, including recruitment of participants, setting, designing, delivery and [https://freshbookmarking.com/story18328847/7-simple-secrets-to-totally-refreshing-your-pragmatic-free 프라그마틱 무료스핀] execution of interventions, determining and analysis results, as well as primary analyses. This is a major difference between explanatory trials as defined by Schwartz &amp; Lellouch1,  [https://pragmatickorea45556.wikirecognition.com/1020522/the_12_most_obnoxious_types_of_the_twitter_accounts_that_you_follow 프라그마틱 슈가러쉬] which are designed to prove the hypothesis in a more thorough manner.<br><br>Studies that are truly practical should avoid attempting to blind participants or clinicians in order to result in bias in estimates of the effect of treatment. Pragmatic trials will also recruit patients from different health care settings to ensure that the results can be applied to the real world.<br><br>Furthermore studies that are pragmatic should focus on outcomes that are vital to patients, like quality of life or functional recovery. This is particularly relevant for trials that involve surgical procedures that are invasive or may have harmful adverse effects. The CRASH trial29, for  [https://redhotbookmarks.com/story18270202/20-fun-details-about-pragmatic-kr 프라그마틱 사이트] example focused on the functional outcome to compare a 2-page case-report with an electronic system to monitor the health of patients in hospitals suffering from chronic heart failure. Similarly, the catheter trial28 used urinary tract infections caused by catheters as the primary outcome.<br><br>In addition to these characteristics, pragmatic trials should minimize trial procedures and data-collection requirements to cut costs and time commitments. In the end the aim of pragmatic trials is to make their results as applicable to current clinical practices as they can. This can be accomplished by ensuring their primary analysis is based on the intention-to treat method (as defined in CONSORT extensions).<br><br>Despite these criteria however, a large number of RCTs with features that challenge the notion of pragmatism were incorrectly labeled pragmatic and published in journals of all kinds. This can lead to misleading claims of pragmatism and the use of the term should be standardized. The development of a PRECIS-2 tool that provides an objective and standardized evaluation of the pragmatic characteristics is the first step.<br><br>Methods<br><br>In a pragmatic trial it is the intention to inform policy or clinical decisions by demonstrating how the intervention can be incorporated into real-world routine care. This differs from explanation trials that test hypotheses about the cause-effect connection in idealized situations. In this way, pragmatic trials could have a lower internal validity than explanation studies and be more susceptible to biases in their design analysis, [https://companyspage.com/story3620392/why-pragmatic-korea-isn-t-a-topic-that-people-are-interested-in 프라그마틱 사이트] conduct, and design. Despite these limitations, pragmatic trials may provide valuable information to decisions in the context of healthcare.<br><br>The PRECIS-2 tool evaluates an RCT on 9 domains, with scores ranging from 1 to 5 (very pragmatic). In this study, the recruitment, organisation, flexibility: delivery and follow-up domains received high scores, but the primary outcome and the method of missing data were below the limit of practicality. This suggests that it is possible to design a trial that has good pragmatic features without damaging the quality of its outcomes.<br><br>It is, however, difficult to judge the degree of pragmatism a trial really is because pragmatism is not a binary attribute; some aspects of a study can be more pragmatic than others. A trial's pragmatism can be affected by modifications to the protocol or the logistics during the trial. Additionally, 36% of the 89 pragmatic trials identified by Koppenaal and colleagues were placebo-controlled or conducted prior to licensing and most were single-center. They are not in line with the norm and can only be referred to as pragmatic if the sponsors agree that the trials aren't blinded.<br><br>Additionally, a typical feature of pragmatic trials is that researchers attempt to make their findings more meaningful by analysing subgroups of the trial sample. This can result in unbalanced analyses with less statistical power. This increases the chance of omitting or misinterpreting differences in the primary outcomes. This was the case in the meta-analysis of pragmatic trials due to the fact that secondary outcomes were not corrected for differences in covariates at baseline.<br><br>Furthermore, pragmatic studies can pose difficulties in the gathering and interpretation of safety data. It is because adverse events tend to be self-reported and are susceptible to errors, delays or coding variations. Therefore, it is crucial to improve the quality of outcome for these trials, and ideally by using national registries instead of relying on participants to report adverse events in a trial's own database.<br><br>Results<br><br>Although the definition of pragmatism does not require that clinical trials be 100% pragmatist There are advantages when incorporating pragmatic components into trials. These include:<br><br>Increasing sensitivity to real-world issues as well as reducing the size of studies and their costs as well as allowing trial results to be more quickly implemented into clinical practice (by including patients who are routinely treated). However, pragmatic trials can also have disadvantages. For instance, the appropriate type of heterogeneity could help the trial to apply its findings to a variety of settings and patients. However the wrong kind of heterogeneity may reduce the assay's sensitivity and therefore reduce the power of a study to detect small treatment effects.<br><br>Many studies have attempted classify pragmatic trials using different definitions and scoring methods. Schwartz and Lellouch1 developed a framework for distinguishing between explanation-based trials that support a clinical or physiological hypothesis and pragmatic trials that help in the selection of appropriate treatments in clinical practice. The framework was composed of nine domains evaluated on a scale of 1-5 which indicated that 1 was more informative and 5 was more pragmatic. The domains covered recruitment and setting up, the delivery of intervention, flexible adhering to the program and primary analysis.<br><br>The original PRECIS tool3 featured similar domains and an assessment scale ranging from 1 to 5. Koppenaal et al10 created an adaptation of this assessment called the Pragmascope that was easier to use in systematic reviews. They discovered that pragmatic reviews scored higher on average in most domains, but scored lower in the primary analysis domain.<br><br>This distinction in the primary analysis domains could be due to the way in which most pragmatic trials analyse data. Certain explanatory trials however do not. The overall score for pragmatic systematic reviews was lower when the domains of management, flexible delivery and follow-up were merged.<br><br>It is important to understand that a pragmatic trial does not necessarily mean a low-quality trial, [https://rankuppages.com/story3664538/you-ll-never-guess-this-pragmatic-genuine-s-tricks 프라그마틱 무료체험] and there is a growing number of clinical trials (as defined by MEDLINE search, but it is neither specific nor sensitive) that use the term "pragmatic" in their abstract or title. These terms could indicate that there is a greater understanding of pragmatism in abstracts and [https://atozbookmarkc.com/story18516724/14-misconceptions-common-to-pragmatic-play 프라그마틱 슬롯 사이트] titles, however it's not clear if this is reflected in content.<br><br>Conclusions<br><br>In recent times, pragmatic trials are increasing in popularity in research because the importance of real-world evidence is increasingly recognized. They are clinical trials that are randomized which compare real-world treatment options instead of experimental treatments under development. They involve patients that more closely mirror the patients who receive routine care, they employ comparators which exist in routine practice (e.g. existing medications) and rely on participant self-report of outcomes. This approach has the potential to overcome limitations of observational studies that are prone to limitations of relying on volunteers and the lack of availability and the variability of coding in national registries.<br><br>Pragmatic trials have other advantages, like the ability to use existing data sources and a higher chance of detecting significant distinctions from traditional trials. However, these tests could have some limitations that limit their effectiveness and generalizability. The participation rates in certain trials may be lower than anticipated due to the health-promoting effect, financial incentives, or competition from other research studies. Many pragmatic trials are also restricted by the necessity to recruit participants in a timely manner. Additionally certain pragmatic trials do not have controls to ensure that the observed differences aren't due to biases in trial conduct.<br><br>The authors of the Pragmatic Free Trial Meta identified RCTs published up to 2022 that self-described as pragmatic. They assessed pragmatism by using the PRECIS-2 tool, which includes the eligibility criteria for domains as well as recruitment, flexibility in adherence to intervention, and follow-up. They found 14 trials scored highly pragmatic or pragmatic (i.e. scoring 5 or above) in at least one of these domains.<br><br>Trials with a high pragmatism rating tend to have broader eligibility criteria than traditional RCTs which have very specific criteria that are unlikely to be found in the clinical environment, and they include populations from a wide range of hospitals. According to the authors, may make pragmatic trials more relevant and useful in everyday practice. However, they cannot ensure that a study is free of bias. The pragmatism principle is not a fixed attribute and a test that doesn't have all the characteristics of an explicative study may still yield valid and useful outcomes.
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trial Meta is a non-commercial, open data platform and infrastructure that facilitates research on pragmatic trials. It collects and distributes clean trial data, ratings and evaluations using PRECIS-2. This allows for diverse meta-epidemiological analyses that compare treatment effect estimates across trials with different levels of pragmatism.<br><br>Background<br><br>Pragmatic trials are becoming more widely recognized as providing real-world evidence to support clinical decision-making. The term "pragmatic", however, is not used in a consistent manner and its definition and measurement require further clarification. Pragmatic trials must be designed to inform clinical practice and policy decisions, rather than confirm an hypothesis that is based on a clinical or physiological basis. A pragmatic study should try to be as similar to actual clinical practice as is possible, including its participation of participants, setting up and design, the delivery and execution of the intervention, and the determination and analysis of the outcomes, and primary analysis. This is a significant difference between explanation-based trials,  [https://bookmark-master.com/story18315725/what-experts-from-the-field-of-pragmatic-slots-site-want-you-to-know 프라그마틱 추천] as defined by Schwartz and Lellouch1 which are designed to test a hypothesis in a more thorough manner.<br><br>Truely pragmatic trials should not blind participants or clinicians. This can lead to an overestimation of the effects of treatment. Practical trials should also aim to recruit patients from a variety of health care settings, so that their results can be applied to the real world.<br><br>Furthermore studies that are pragmatic should focus on outcomes that are crucial to patients, like quality of life or functional recovery. This is particularly relevant when trials involve the use of invasive procedures or could have harmful adverse effects. The CRASH trial29 compared a 2-page report with an electronic monitoring system for patients in hospitals with chronic heart failure. The trial with a catheter, on the other hand, used symptomatic catheter associated urinary tract infection as its primary outcome.<br><br>In addition to these aspects pragmatic trials should reduce the trial procedures and data collection requirements in order to reduce costs. Additionally these trials should strive to make their results as applicable to current clinical practices as they can. This can be achieved by ensuring their primary analysis is based on the intention to treat method (as defined in CONSORT extensions).<br><br>Despite these criteria, many RCTs with features that defy the concept of pragmatism have been mislabeled as pragmatic and published in journals of all kinds. This can lead to misleading claims of pragmatism, and the usage of the term should be standardized. The creation of the PRECIS-2 tool, which offers a standard objective assessment of practical features, is a good first step.<br><br>Methods<br><br>In a practical trial, the aim is to inform clinical or policy decisions by demonstrating how the intervention can be implemented into routine care. Explanatory trials test hypotheses about the cause-effect relation within idealized settings. In this way, pragmatic trials could have less internal validity than explanatory studies and be more prone to biases in their design, analysis, and conduct. Despite these limitations, pragmatic trials may provide valuable information to decisions in the context of healthcare.<br><br>The PRECIS-2 tool scores an RCT on 9 domains, ranging from 1 to 5 (very pragmatic). In this study, the areas of recruitment, organisation, flexibility in delivery,  [https://stevez441mga6.like-blogs.com/profile 프라그마틱 무료] flexible adherence, and follow-up were awarded high scores. However, the primary outcome and the method of missing data scored below the pragmatic limit. This suggests that it is possible to design a trial that has good pragmatic features without compromising the quality of its results.<br><br>However, it's difficult to determine the degree of pragmatism a trial really is because pragmatism is not a binary attribute; some aspects of a study can be more pragmatic than others. A trial's pragmatism could be affected by modifications to the protocol or logistics during the trial. Koppenaal and colleagues discovered that 36% of 89 pragmatic studies were placebo-controlled or conducted prior to licensing. The majority of them were single-center. This means that they are not very close to usual practice and can only be called pragmatic when their sponsors are accepting of the lack of blinding in such trials.<br><br>A typical feature of pragmatic studies is that researchers attempt to make their findings more meaningful by studying subgroups within the trial sample. This can result in imbalanced analyses and less statistical power. This increases the risk of omitting or ignoring differences in the primary outcomes. In the instance of the pragmatic trials included in this meta-analysis this was a major issue because the secondary outcomes were not adjusted for variations in the baseline covariates.<br><br>In addition, pragmatic studies can present challenges in the collection and  [https://mypresspage.com/story3688843/10-healthy-pragmatic-free-trial-habits 무료슬롯 프라그마틱] interpretation safety data. This is due to the fact that adverse events are usually self-reported and are prone to reporting delays, inaccuracies, or coding variations. Therefore, it is crucial to enhance the quality of outcomes assessment in these trials, ideally by using national registries instead of relying on participants to report adverse events in the trial's own database.<br><br>Results<br><br>Although the definition of pragmatism does not require that all trials are 100 100% pragmatic, there are advantages to including pragmatic components in clinical trials. These include:<br><br>Increased sensitivity to real-world issues which reduces cost and size of the study and allowing the study results to be faster transferred into real-world clinical practice (by including patients who are routinely treated). However, pragmatic trials may have disadvantages. The right type of heterogeneity, like, can help a study expand its findings to different settings or patients. However, the wrong type can reduce the assay sensitivity and, consequently,  [https://mypresspage.com/ 프라그마틱 슬롯 무료체험] decrease the ability of a study to detect minor treatment effects.<br><br>Numerous studies have attempted to classify pragmatic trials with a variety of definitions and [https://pragmatic-korea68901.liberty-blog.com/ 프라그마틱 홈페이지] scoring systems. Schwartz and Lellouch1 developed a framework for distinguishing between explanation-based trials that support a physiological or clinical hypothesis, and pragmatic trials that aid in the selection of appropriate therapies in the real-world clinical setting. The framework was comprised of nine domains that were scored on a scale ranging from 1 to 5, with 1 indicating more lucid and 5 suggesting more pragmatic. The domains included recruitment and setting, delivery of intervention, flexible adherence, follow-up and primary analysis.<br><br>The original PRECIS tool3 was based on a similar scale and domains. Koppenaal et. al10 devised an adaptation of the assessment, known as the Pragmascope which was more user-friendly to use for systematic reviews. They discovered that pragmatic reviews scored higher on average in most domains, but scored lower in the primary analysis domain.<br><br>This difference in primary analysis domains could be explained by the way that most pragmatic trials analyze data. Some explanatory trials, however do not. The overall score was lower for pragmatic systematic reviews when the domains of the organization, flexibility of delivery and follow-up were merged.<br><br>It is important to note that the term "pragmatic trial" does not necessarily mean a low-quality trial, and indeed there is a growing number of clinical trials (as defined by MEDLINE search, but it is neither sensitive nor specific) that employ the term "pragmatic" in their abstract or title. These terms may indicate an increased understanding of pragmatism in abstracts and titles, but it's not clear whether this is evident in the content.<br><br>Conclusions<br><br>As the value of real-world evidence becomes increasingly commonplace and pragmatic trials have gained momentum in research. They are randomized clinical trials that evaluate real-world alternatives to care rather than experimental treatments under development, they have patients that are more similar to those treated in routine care, they employ comparators which exist in routine practice (e.g. existing medications), and they depend on participants' self-reports of outcomes. This method is able to overcome the limitations of observational research such as the biases that come with the reliance on volunteers, and the lack of coding variations in national registries.<br><br>Pragmatic trials have other advantages, including the ability to leverage existing data sources and a greater chance of detecting significant differences than traditional trials. However, they may have some limitations that limit their validity and generalizability. For instance, participation rates in some trials may be lower than expected due to the healthy-volunteer effect and financial incentives or competition for participants from other research studies (e.g. industry trials). A lot of pragmatic trials are limited by the need to recruit participants on time. Certain pragmatic trials lack controls to ensure that the observed differences aren't caused by biases that occur during the trial.<br><br>The authors of the Pragmatic Free Trial Meta identified 48 RCTs that self-described themselves as pragmatist and published from 2022. They assessed pragmatism by using the PRECIS-2 tool that includes the eligibility criteria for domains as well as recruitment, flexibility in adherence to interventions and follow-up. They discovered that 14 of the trials scored pragmatic or highly practical (i.e. scores of 5 or higher) in any one or more of these domains and that the majority of them were single-center.<br><br>Studies with high pragmatism scores tend to have broader criteria for eligibility than traditional RCTs. They also include populations from various hospitals. These characteristics, according to the authors, can make pragmatic trials more useful and applicable in the daily practice. However, they don't guarantee that a trial is free of bias. The pragmatism is not a fixed attribute; a pragmatic test that does not possess all the characteristics of an explanation study could still yield reliable and beneficial results.

Latest revision as of 10:52, 23 December 2024

Pragmatic Free Trial Meta

Pragmatic Free Trial Meta is a non-commercial, open data platform and infrastructure that facilitates research on pragmatic trials. It collects and distributes clean trial data, ratings and evaluations using PRECIS-2. This allows for diverse meta-epidemiological analyses that compare treatment effect estimates across trials with different levels of pragmatism.

Background

Pragmatic trials are becoming more widely recognized as providing real-world evidence to support clinical decision-making. The term "pragmatic", however, is not used in a consistent manner and its definition and measurement require further clarification. Pragmatic trials must be designed to inform clinical practice and policy decisions, rather than confirm an hypothesis that is based on a clinical or physiological basis. A pragmatic study should try to be as similar to actual clinical practice as is possible, including its participation of participants, setting up and design, the delivery and execution of the intervention, and the determination and analysis of the outcomes, and primary analysis. This is a significant difference between explanation-based trials, 프라그마틱 추천 as defined by Schwartz and Lellouch1 which are designed to test a hypothesis in a more thorough manner.

Truely pragmatic trials should not blind participants or clinicians. This can lead to an overestimation of the effects of treatment. Practical trials should also aim to recruit patients from a variety of health care settings, so that their results can be applied to the real world.

Furthermore studies that are pragmatic should focus on outcomes that are crucial to patients, like quality of life or functional recovery. This is particularly relevant when trials involve the use of invasive procedures or could have harmful adverse effects. The CRASH trial29 compared a 2-page report with an electronic monitoring system for patients in hospitals with chronic heart failure. The trial with a catheter, on the other hand, used symptomatic catheter associated urinary tract infection as its primary outcome.

In addition to these aspects pragmatic trials should reduce the trial procedures and data collection requirements in order to reduce costs. Additionally these trials should strive to make their results as applicable to current clinical practices as they can. This can be achieved by ensuring their primary analysis is based on the intention to treat method (as defined in CONSORT extensions).

Despite these criteria, many RCTs with features that defy the concept of pragmatism have been mislabeled as pragmatic and published in journals of all kinds. This can lead to misleading claims of pragmatism, and the usage of the term should be standardized. The creation of the PRECIS-2 tool, which offers a standard objective assessment of practical features, is a good first step.

Methods

In a practical trial, the aim is to inform clinical or policy decisions by demonstrating how the intervention can be implemented into routine care. Explanatory trials test hypotheses about the cause-effect relation within idealized settings. In this way, pragmatic trials could have less internal validity than explanatory studies and be more prone to biases in their design, analysis, and conduct. Despite these limitations, pragmatic trials may provide valuable information to decisions in the context of healthcare.

The PRECIS-2 tool scores an RCT on 9 domains, ranging from 1 to 5 (very pragmatic). In this study, the areas of recruitment, organisation, flexibility in delivery, 프라그마틱 무료 flexible adherence, and follow-up were awarded high scores. However, the primary outcome and the method of missing data scored below the pragmatic limit. This suggests that it is possible to design a trial that has good pragmatic features without compromising the quality of its results.

However, it's difficult to determine the degree of pragmatism a trial really is because pragmatism is not a binary attribute; some aspects of a study can be more pragmatic than others. A trial's pragmatism could be affected by modifications to the protocol or logistics during the trial. Koppenaal and colleagues discovered that 36% of 89 pragmatic studies were placebo-controlled or conducted prior to licensing. The majority of them were single-center. This means that they are not very close to usual practice and can only be called pragmatic when their sponsors are accepting of the lack of blinding in such trials.

A typical feature of pragmatic studies is that researchers attempt to make their findings more meaningful by studying subgroups within the trial sample. This can result in imbalanced analyses and less statistical power. This increases the risk of omitting or ignoring differences in the primary outcomes. In the instance of the pragmatic trials included in this meta-analysis this was a major issue because the secondary outcomes were not adjusted for variations in the baseline covariates.

In addition, pragmatic studies can present challenges in the collection and 무료슬롯 프라그마틱 interpretation safety data. This is due to the fact that adverse events are usually self-reported and are prone to reporting delays, inaccuracies, or coding variations. Therefore, it is crucial to enhance the quality of outcomes assessment in these trials, ideally by using national registries instead of relying on participants to report adverse events in the trial's own database.

Results

Although the definition of pragmatism does not require that all trials are 100 100% pragmatic, there are advantages to including pragmatic components in clinical trials. These include:

Increased sensitivity to real-world issues which reduces cost and size of the study and allowing the study results to be faster transferred into real-world clinical practice (by including patients who are routinely treated). However, pragmatic trials may have disadvantages. The right type of heterogeneity, like, can help a study expand its findings to different settings or patients. However, the wrong type can reduce the assay sensitivity and, consequently, 프라그마틱 슬롯 무료체험 decrease the ability of a study to detect minor treatment effects.

Numerous studies have attempted to classify pragmatic trials with a variety of definitions and 프라그마틱 홈페이지 scoring systems. Schwartz and Lellouch1 developed a framework for distinguishing between explanation-based trials that support a physiological or clinical hypothesis, and pragmatic trials that aid in the selection of appropriate therapies in the real-world clinical setting. The framework was comprised of nine domains that were scored on a scale ranging from 1 to 5, with 1 indicating more lucid and 5 suggesting more pragmatic. The domains included recruitment and setting, delivery of intervention, flexible adherence, follow-up and primary analysis.

The original PRECIS tool3 was based on a similar scale and domains. Koppenaal et. al10 devised an adaptation of the assessment, known as the Pragmascope which was more user-friendly to use for systematic reviews. They discovered that pragmatic reviews scored higher on average in most domains, but scored lower in the primary analysis domain.

This difference in primary analysis domains could be explained by the way that most pragmatic trials analyze data. Some explanatory trials, however do not. The overall score was lower for pragmatic systematic reviews when the domains of the organization, flexibility of delivery and follow-up were merged.

It is important to note that the term "pragmatic trial" does not necessarily mean a low-quality trial, and indeed there is a growing number of clinical trials (as defined by MEDLINE search, but it is neither sensitive nor specific) that employ the term "pragmatic" in their abstract or title. These terms may indicate an increased understanding of pragmatism in abstracts and titles, but it's not clear whether this is evident in the content.

Conclusions

As the value of real-world evidence becomes increasingly commonplace and pragmatic trials have gained momentum in research. They are randomized clinical trials that evaluate real-world alternatives to care rather than experimental treatments under development, they have patients that are more similar to those treated in routine care, they employ comparators which exist in routine practice (e.g. existing medications), and they depend on participants' self-reports of outcomes. This method is able to overcome the limitations of observational research such as the biases that come with the reliance on volunteers, and the lack of coding variations in national registries.

Pragmatic trials have other advantages, including the ability to leverage existing data sources and a greater chance of detecting significant differences than traditional trials. However, they may have some limitations that limit their validity and generalizability. For instance, participation rates in some trials may be lower than expected due to the healthy-volunteer effect and financial incentives or competition for participants from other research studies (e.g. industry trials). A lot of pragmatic trials are limited by the need to recruit participants on time. Certain pragmatic trials lack controls to ensure that the observed differences aren't caused by biases that occur during the trial.

The authors of the Pragmatic Free Trial Meta identified 48 RCTs that self-described themselves as pragmatist and published from 2022. They assessed pragmatism by using the PRECIS-2 tool that includes the eligibility criteria for domains as well as recruitment, flexibility in adherence to interventions and follow-up. They discovered that 14 of the trials scored pragmatic or highly practical (i.e. scores of 5 or higher) in any one or more of these domains and that the majority of them were single-center.

Studies with high pragmatism scores tend to have broader criteria for eligibility than traditional RCTs. They also include populations from various hospitals. These characteristics, according to the authors, can make pragmatic trials more useful and applicable in the daily practice. However, they don't guarantee that a trial is free of bias. The pragmatism is not a fixed attribute; a pragmatic test that does not possess all the characteristics of an explanation study could still yield reliable and beneficial results.